Increase in Prescription Drug Cost and Its Economic – part 10
Posted by admin in Business EssaysThe following table shows the Percent change in manufacturer prices in 2004 for rheumatology-related drugs in the top 25 brand-name prescription drugs (Rheumawire News, 2005).
|
Drug trade name and dose |
Manufacturer |
% change in manufacturer prices |
|
Fosamax 70 mg |
Merck |
6.7 |
|
Lipitor 10 mg |
Pfizer |
6.4 |
|
Lipitor 20 mg |
Pfizer |
2.9 |
|
Prevacid |
TAP |
3.3 |
|
Celebrex |
Pfizer |
6.6 |
|
Protonix 40 mg |
Wyeth |
5.0 |
|
Nexium 40 mg |
Astrazeneca |
6.1 |
|
Actonel 35 mg |
Proctor and gamble |
7.6 |
|
Pravachol 40 mg |
Bristo-myers squibb |
7.0 |
|
Pravachol 20 mg |
Bristo-myers squibb |
7.0 |
|
Evista 60 mg |
Lilly |
7.8 |
|
Lipitor 40 mg |
Pfizer |
2.9 |
|
Toprol xl 50 mg |
AstraZeneca |
9.1 |
|
Zocor 20 mg |
Merck |
3.6 |
